Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CASI
#3957
CASI Pharmaceuticals, Inc. Ordinary Shares
0.2
1
-73.75%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-73.75%
Monatliche Änderung
-78.79%
6 month change
-90.41%
Jahresänderung
-91.36%
Vorheriger Schlusskurs
0.8
0
Open
0.2
1
Bid
Ask
Low
0.2
1
High
0.2
1
Volumen
17
Märkte
Aktien
Gesundheitswesen
CASI
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
13.46 M
13.38 M
15.49 M
—
Valuation ratios
Enterprise value
—
79.49 M
30.34 M
—
Price to earnings ratio
—
-3.57
-1.11
—
Price to sales ratio
—
2.85
1.52
—
Price to cash flow ratio
—
-4.83
-1.49
—
Price to book ratio
—
3.99
23.45
—
Enterprise value to EBITDA ratio
—
-24.24
-0.78
—
Profitability ratios
Return on assets %
0.43
0.36
0.73
—
Return on equity %
0.92
1.12
21.21
—
Return on invested capital %
337.4
264.42
384.92
—
Gross margin %
63.28
59.19
39.06
—
Operating margin %
78.95
74.03
138.84
—
EBITDA margin %
-76.95
-9.68
-137.34
—
Net margin %
95.14
79.58
137.57
—
Liquidity ratios
Quick ratio
3.96
2.6
0.94
—
Current ratio
4.32
3.55
1.09
—
Inventory turnover
2.58
1.25
1.64
—
Asset turnover
0.45
0.4
0.44
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
0.25
0.35
—
Long term debt to total equity ratio
—
0.78
10.21
—
Per share metrics
Operating cash flow per share
1.55
1.49
1.9
—
EBIT per share
-2.52
-0.43
-2.64
—
EBITDA per share
-2.43
-0.25
-2.55
—
Total debt per share
—
—
—
—
Cash per share
3.65
2.18
0.99
—
Net current asset value per share
5.38
4.44
2.58
—
Tangible book value per share
3.19
1.67
0.11
—
Working capital per share
4.13
3.19
0.2
—
Book value per share
3.27
1.81
0.12
—
Nachrichten
What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%
NASDAQ-Delisting: Aktie von CASI Pharmaceuticals bricht ein
CASI Pharmaceuticals stock plunges on Nasdaq delisting notice
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection
NASDAQ gewährt CASI Pharmaceuticals Aufschub – Aktie legt nachbörslich deutlich zu
Casi Pharmaceuticals sichert sich Fristverlängerung für NASDAQ-Listing bis Februar 2026
CASI Pharmaceuticals stock surges after Nasdaq grants listing extension
Casi Pharmaceuticals secures Nasdaq listing extension until February 2026
CASI Pharmaceuticals secures $20 million funding for transplant rejection study